Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
64.00    0.30 (0.47%)
Bid:
63.60
Ask:
64.30
Spread: 0.70 (1.101%)
Market Cap: £565.39m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Ip Group News

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair
15 Nov 2021

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC
11 Nov 2021

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

IP Group portfolio company inks joint development agreement with Ceres Power
11 Nov 2021

IP Group portfolio company inks joint development agreement with Ceres Power

(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, h...

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion
29 Oct 2021

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

IN BRIEF: IP Group books GBP27.5 million fair value gain
25 Oct 2021

IN BRIEF: IP Group books GBP27.5 million fair value gain

IN BRIEF: IP Group books GBP27.5 million fair value gain

IP Group records £27.5m value gain after recent funding round
25 Oct 2021

IP Group records £27.5m value gain after recent funding round

(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portf...

Oxford BioMedica licences technology for cystic fibrosis treatment
19 Oct 2021

Oxford BioMedica licences technology for cystic fibrosis treatment

Oxford BioMedica licences technology for cystic fibrosis treatment

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology
19 Oct 2021

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology

(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option...